Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger. In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes ...
In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued at $688 ...
This price reflects trading activity during the overnight session on the Blue Ocean ATS, available 8 PM to 4 AM ET, Sunday through Thursday, when regular markets are closed. The above button links to ...
So, you’re looking to get better at coding interviews, huh? Maybe you’ve heard about LeetCode and feel a bit lost. It’s ...
Recursion Pharmaceuticals insiders reported 5 transactions totaling $366,367.08. Activity included 2 stock sales and 1 tax-related share disposition, with 2 additional non-cash transactions. Updated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results